To cure leukemia, lymphoma, Hodgkin's disease and myeloma, and to improve the quality of life of patients and their families.
The Leukemia & Lymphoma Societyinc directs most of its recent giving to research institutions working on blood cancers, with repeated large awards to Dana-Farber Cancer Institute in Boston and to Joan & Sanford I Weill Medical College of Cornell University in New York. Its stated purpose is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and to improve the quality of life of patients and their families, and its active programs show that this mission reaches both laboratory science and patient support. Alongside research grants, the organization runs assistance programs for treatment-related costs, travel, medical debt, urgent needs, and scholarships for blood cancer survivors. The grant record also includes therapy acceleration support, indicating an interest in moving candidate treatments closer to patients. Recent awards span major cancer centers, medical schools, and research institutes across the United States, including the University of Texas MD Anderson Cancer Center, Sloan Kettering Institute for Cancer Research, Stanford, Washington University in St. Louis, and University of Florida. The pattern is one of large, project-specific grants to established biomedical and clinical research recipients, paired with direct financial aid programs for people affected by blood cancer.
In cancer research, the foundation has backed Dana-Farber Cancer Institute twice in the latest grant list, including a 2025 research grant and a 2024 research grant, both above $4 million. It also funded The University of Texas MD Anderson Cancer Center with separate research grants in 2024 and 2025. For translational work, Dren Bio received a 2025 therapy acceleration award, showing support for moving candidate therapies forward. The organization also funds clinical research institutions such as Sloan Kettering Institute for Cancer Research and Washington University in St. Louis through research grants. Beyond research, its active programs include co-pay assistance, patient aid, patient travel assistance, and urgent need support for eligible blood cancer patients in the United States.
Typical grants sit in the high six-figure to seven-figure range: the p25 is $125,000, the median is $303,000, and the p75 is $834,999. The recent list shows many awards well above that median, reflecting a mix of mid-sized and major project grants. Recipients also reappear across years and often receive multiple awards, such as research institutions in Boston, New York, Houston, and Gainesville. The organization is a regular funder, makes program-related investments, and does not fund individuals directly. Several active patient-assistance programs accept unsolicited applications.
$47.7M
$532.2M
$358.7M
$398.1M
Most grants fall between $125K and $835K, with a median of $303K.
25th Percentile
$125K
Median
$303K
75th Percentile
$835K
About 1% of grants go to recipients in CA.
E ANDERS KOLB MD
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Grantmaking is national, and the recipient country distribution is entirely U.S.-based. The top state by grant count is Massachusetts, with Boston appearing repeatedly among the largest recent awards. Other frequent recipient locations include New York, Houston, St. Louis, Gainesville, Atlanta, and Stanford/San Francisco, showing a broad reach to major cancer centers and medical schools. No grants in the recent list go to recipients outside the United States.
Its recent grants go to research institutions, medical schools, and cancer centers, including Dana-Farber Cancer Institute, Sloan Kettering Institute for Cancer Research, Washington University in St. Louis, and the University of Florida. The foundation’s stated focus includes blood cancers, patient financial assistance, cancer research funding, advocacy and policy, and translational or clinical research support.
Yes. Active programs include Medical Debt Case Management, Co-Pay Assistance, Local Financial Assistance, Pre-CAR T-cell Therapy Travel Assistance, Urgent Need Programs, Patient Travel Assistance, and Patient Aid. It also offers Scholarships for Blood Cancer Survivors.
The grant-size distribution is centered on sizeable awards: p25 is $125,000, the median is $303,000, and p75 is $834,999. Recent grants show much larger project awards as well, including multi-million-dollar research and therapy acceleration grants.
Yes. The geographic scope of giving is national, and the recipient country distribution is 100% U.S. The recent grant list includes recipients in Boston, New York, Houston, St. Louis, Gainesville, Atlanta, Seattle, Philadelphia, and Aurora.
Yes. Several active patient-support programs accept unsolicited applications, including Scholarships for Blood Cancer Survivors, Co-Pay Assistance Program, Local Financial Assistance Program, Pre-CAR T-cell Therapy Travel Assistance Program, Urgent Need Programs, Patient Travel Assistance Program, and Patient Aid Program.
2026
Source: IRS Form 990-PF, fiscal year 2026.
Current and upcoming funding from Leukemia & Lymphoma Societyinc that your nonprofit may be able to apply for.
Who can apply: For research projects examining how health insurance affects access to care. Applicants submit a letter of intent.
Deadline: LOIs due 9/10/26.
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| DANA-FARBER CANCER INSTITUTE INC | BOSTON, MA | $5,197,687 | 2026 | RESEARCH GRANT |
| THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | HOUSTON, TX | $2,518,448 | 2026 | RESEARCH GRANT |
| SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH | NEW YORK, NY | $2,513,800 | 2026 | RESEARCH GRANT |
| THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | STANFORD, CA | $2,257,440 | 2026 | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | ST LOUIS, MO | $2,252,023 | 2026 | RESEARCH GRANT |
| JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | NEW YORK, NY | $2,115,000 | 2026 | RESEARCH GRANT |
| UNIVERSITY OF FLORIDA | GAINESVILLE, FL | $2,009,874 | 2026 | RESEARCH GRANT |
| UNIVERSITY OF COLORADO DENVER ANSCHUTZ MEDICAL CAMPUS | AURORA, CO | $1,966,500 | 2026 | RESEARCH GRANT |
| EMORY UNIVERSITY | ATLANTA, GA | $1,661,071 | 2026 | RESEARCH GRANT |
| FRED HUTCHINSON CANCER CENTER | SEATTLE, WA | $1,550,000 | 2026 | RESEARCH GRANT |
| H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE | ATLANTA, GA | $1,312,498 | 2026 | RESEARCH GRANT |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL | MEMPHIS, TN | $1,308,000 | 2026 | RESEARCH GRANT |
| UNIVERSITY OF MIAMI | ATLANTA, GA | $1,280,887 | 2026 | RESEARCH GRANT |
| NEW YORK COLUMBIA UNIVERSITY MEDICAL CENTER | NEW YORK, NY | $1,173,600 | 2026 | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $1,073,600 | 2026 | RESEARCH GRANT |
| THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA MEDICAL CENTER | PHILADELPHIA, PA | $1,069,925 | 2026 | RESEARCH GRANT |
| UNIVERSITY OF VIRGINIA | CHARLOTTESVILLE, VA | $999,997 | 2026 | RESEARCH GRANT |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | SAN FRANCISCO, CA | $945,000 | 2026 | RESEARCH GRANT |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | BRONX, NY | $943,343 | 2026 | RESEARCH GRANT |
| BOSTON CHILDREN'S HOSPITAL | BOSTON, MA | $750,000 | 2026 | RESEARCH GRANT |
| YALE UNIVERSITY | NEW HAVEN, CT | $664,225 | 2026 | RESEARCH GRANT |
| PERELMAN SCHOOL OF MEDICINE AT THE UNIVERSITY OF PENNSYLVANIA | PHILADELPHIA, PA | $640,000 | 2026 | RESEARCH GRANT |
| THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER | PHILADELPHIA, PA | $620,000 | 2026 | RESEARCH GRANT |
| OSU FOUNDATION | COLUMBUS, OH | $579,132 | 2026 | RESEARCH GRANT |
| INDIANA UNIVERSITY | FORT WAYNE, IN | $504,297 | 2026 | RESEARCH GRANT |
| CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | CINCINATTI, OH | $500,541 | 2026 | RESEARCH GRANT |
| AURON THERAPEUTICS | NEWTON, MA | $500,000 | 2026 | THERAPY ACCELERATION |
| HOUSTON METHODIST RESEARCH INSTITUTE | HOUSTON, TX | $500,000 | 2026 | RESEARCH GRANT |
| DURHAM VA MEDICAL CENTER | DURHAM, NC | $500,000 | 2026 | RESEARCH GRANT |
| SOLU THERAPEUTICS | BOSTON, MA | $499,999 | 2026 | THERAPY ACCELERATION |
| VANDERBILT UNIVERSITY MEDICAL CENTER | DALLAS, TX | $424,913 | 2026 | RESEARCH GRANT |
| THE MEDICAL COLLEGE OF WISCONSIN | MILWAUKEE, WI | $375,000 | 2026 | RESEARCH GRANT |
| BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | DUARTE, CA | $375,000 | 2026 | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | DALLAS, TX | $370,000 | 2026 | RESEARCH GRANT |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | LA JOLLA, CA | $370,000 | 2026 | RESEARCH GRANT |
| THE OHIO STATE UNIVERSITY | COLUMBUS, OH | $296,867 | 2026 | RESEARCH GRANT |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | PHILADELPHIA, PA | $284,000 | 2026 | RESEARCH GRANT |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | NEW YORK, NY | $253,000 | 2026 | RESEARCH GRANT |
| UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES | LITTLE ROCK, AR | $250,000 | 2026 | RESEARCH GRANT |
| GEORGE WASHINGTON UNIVERSITY | WASHINGTON, DC | $250,000 | 2026 | RESEARCH GRANT |
| TEXAS A&M UNIVERSITY HEALTH SCIENCE CENTER | BRYAN, TX | $250,000 | 2026 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA AT DAVIS | DAVIS, CA | $250,000 | 2026 | RESEARCH GRANT |
| THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | MANHASSET, NY | $250,000 | 2026 | RESEARCH GRANT |
| THE UNIVERSITY OF TEXAS AT AUSTIN | AUSTIN, TX | $250,000 | 2026 | RESEARCH GRANT |
| SEATTLE CHILDREN'S HOSPITAL | SEATTLE, WA | $249,999 | 2026 | RESEARCH GRANT |
| NYU GROSSMAN SCHOOL OF MEDICINE | NEW YORK, NY | $245,940 | 2026 | RESEARCH GRANT |
| UNIVERSITY OF SOUTHERN CALIFORNIA | LOS ANGELES, CA | $239,560 | 2026 | RESEARCH GRANT |
| DUKE UNIVERSITY MEDICAL CENTER | CHARLOTTE, NC | $194,691 | 2026 | RESEARCH GRANT |
| OREGON HEALTH & SCIENCE UNIVERSITY CANCER INSTITUTE | PORTLAND, OR | $190,000 | 2026 | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY | EVANSTON, IL | $157,406 | 2026 | RESEARCH GRANT |
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
$2,518,448RESEARCH GRANT
SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH
$2,513,800RESEARCH GRANT
RESEARCH GRANT
JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
RESEARCH GRANT
UNIVERSITY OF FLORIDA
$2,009,874RESEARCH GRANT
UNIVERSITY OF COLORADO DENVER ANSCHUTZ MEDICAL CAMPUS
$1,966,500RESEARCH GRANT
EMORY UNIVERSITY
$1,661,071RESEARCH GRANT
MASSACHUSETTS GENERAL HOSPITAL
$1,073,600RESEARCH GRANT
RESEARCH GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
$945,000RESEARCH GRANT
ALBERT EINSTEIN COLLEGE OF MEDICINE
$943,343RESEARCH GRANT
RESEARCH GRANT
OSU FOUNDATION
$579,132RESEARCH GRANT
INDIANA UNIVERSITY
$504,297RESEARCH GRANT
AURON THERAPEUTICS
$500,000THERAPY ACCELERATION
HOUSTON METHODIST RESEARCH INSTITUTE
$500,000RESEARCH GRANT
DURHAM VA MEDICAL CENTER
$500,000RESEARCH GRANT
SOLU THERAPEUTICS
$499,999THERAPY ACCELERATION
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
$370,000RESEARCH GRANT
THE OHIO STATE UNIVERSITY
$296,867RESEARCH GRANT
UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
$250,000RESEARCH GRANT
TEXAS A&M UNIVERSITY HEALTH SCIENCE CENTER
$250,000RESEARCH GRANT
UNIVERSITY OF CALIFORNIA AT DAVIS
$250,000RESEARCH GRANT
THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
$250,000RESEARCH GRANT
THE UNIVERSITY OF TEXAS AT AUSTIN
$250,000RESEARCH GRANT
NYU GROSSMAN SCHOOL OF MEDICINE
$245,940RESEARCH GRANT
